Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXTENZA in bilateral pterygium surgery
NCT04351737Phase 4Completed
- Sponsor
- Brandon Eye Associates
- Start
- Jul 2020
- Primary completion
- Jul 2022
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in Persistent postsurgical pain (PPSP), inflammation, sponsored by Brandon Eye Associates. Started Jul 2020; status: completed.
02
Drugs
ozurdex
03
Conditions
Persistent postsurgical pain (PPSP)inflammation
Beyond the preview
Go deeper on NCT04351737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04351737.